Visualization of human T lymphocyte-mediated eradication of cancer cells in vivo
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Visualization of human T lymphocyte-mediated eradication of cancer cells in vivo
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 117, Issue 37, Pages 22910-22919
Publisher
Proceedings of the National Academy of Sciences
Online
2020-08-29
DOI
10.1073/pnas.2009092117
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Deep Learning Reveals Cancer Metastasis and Therapeutic Antibody Targeting in the Entire Body
- (2019) Chenchen Pan et al. CELL
- Putting the Immunologic Brakes on Cancer
- (2018) Jedd Wolchok CELL
- Fully human CD19-specific chimeric antigen receptors for T-cell therapy
- (2017) D Sommermeyer et al. LEUKEMIA
- A Milestone for CAR T Cells
- (2017) Eric Tran et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tragedy, Perseverance, and Chance — The Story of CAR-T Therapy
- (2017) Lisa Rosenbaum NEW ENGLAND JOURNAL OF MEDICINE
- Single-cell functional and chemosensitive profiling of combinatorial colorectal therapy in zebrafish xenografts
- (2017) Rita Fior et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting CD38 in Refractory Extranodal Natural Killer Cell–T-Cell Lymphoma
- (2016) Parameswaran Hari et al. NEW ENGLAND JOURNAL OF MEDICINE
- Precision medicine for metastatic breast cancer—limitations and solutions
- (2015) Monica Arnedos et al. Nature Reviews Clinical Oncology
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- A phase I clinical trial combining dendritic cell vaccination with adoptive T cell transfer in patients with stage IV melanoma
- (2014) Isabel Poschke et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Novel Mechanism of Macrophage-Mediated Metastasis Revealed in a Zebrafish Model of Tumor Development
- (2014) J. Wang et al. CANCER RESEARCH
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- (2014) Matthew M. Gubin et al. NATURE
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor Immunotherapy Directed at PD-1
- (2012) Antoni Ribas NEW ENGLAND JOURNAL OF MEDICINE
- Tumor Metastasis: Molecular Insights and Evolving Paradigms
- (2011) Scott Valastyan et al. CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Pathological angiogenesis facilitates tumor cell dissemination and metastasis
- (2011) Pegah Rouhi et al. CELL CYCLE
- Hypoxia-induced metastasis model in embryonic zebrafish
- (2010) Pegah Rouhi et al. Nature Protocols
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model
- (2009) Ines J Marques et al. BMC CANCER
- Hypoxia-induced pathological angiogenesis mediates tumor cell dissemination, invasion, and metastasis in a zebrafish tumor model
- (2009) S. L. C. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor-vascular interactions and tumor dormancy
- (2008) GEORGE N. NAUMOV et al. APMIS
- The anticancer immune response: indispensable for therapeutic success?
- (2008) Laurence Zitvogel et al. JOURNAL OF CLINICAL INVESTIGATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started